Medicare Surprise: Drug Plan Prices Touted During Open Enrollment Can Rise Within a Month
Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications is no bargain after prices go up.
Drugs
401-420 of 1,313 results
-
-
Emergency Contraception Marks a New Battle Line in Texas
In the shadow of Texas鈥 austere abortion regulations, grassroots organizers employ stealth tactics to help young women get emergency contraception.
By Sarah Varney -
Journalists Cover the Gamut, From Rising Insulin Costs to Delays in Autism Care for Children
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
-
US Rep. Gaetz鈥檚 Diagnosis of What鈥檚 Driving Insulin Costs Misses the Root Cause
A diabetes diagnosis is not always related to a person鈥檚 weight or overall health, especially for those with Type 1 diabetes, who are dependent on insulin treatment for life.
By Victoria Knight and Colleen DeGuzman -
Perspective
Is My Drug Copay Coupon a Form of Charity 鈥 Or a Bribe?
Drug copayment assistance is a form of profitable charity 鈥 and, yes, that鈥檚 an oxymoron. Amid skyrocketing drug prices, it's understandable that patients desperately need help affording medicine, especially when their health is on the line. But these programs create a mirage that perpetuates our health care system鈥檚 reckless spending.
-
Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
By Arthur Allen -
Journalist Puts in a Plug for Better Sleep Cycles During the Pandemic
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
-
Readers and Tweeters Sound Alarm Over Nurse’s Homicide Trial
KHN gives readers a chance to comment on a recent batch of stories.
-
KHN鈥檚 鈥榃hat the Health?鈥: News You Might Have Missed
Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare鈥檚 coverage decision for the controversial Alzheimer鈥檚 disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
A Travel Nurse Leaves Fears of Hospital Drug Tampering Across Three States
Kentucky nurse Jacqueline Brewster is accused of tampering with opioids in Tennessee and West Virginia, possibly contaminating drugs given to hospital patients.
By Brett Kelman -
Journalists Discuss Insulin Costs and Ethical Questions Surrounding a North Carolina Rehab Program
KHN staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
-
California Handed Its Medicaid Drug Program to One Company. Then Came a Corporate Takeover.
The company awarded the state鈥檚 Medi-Cal Rx contract was taken over by another company, Centene. That left the state with a contractor it didn鈥檛 pick 鈥 one that has been accused of overbilling nine other state Medicaid programs and is now under investigation by California.
-
KHN鈥檚 鈥榃hat the Health?鈥: Finally, a Fix for the 鈥楩amily Glitch鈥
President Joe Biden welcomed former President Barack Obama back to the White House this week to announce a new policy for the Affordable Care Act that would make subsidies available to more families with unaffordable employer coverage. Meanwhile, Congress struggled to find a compromise for continued federal funding of covid-19 vaccines, testing, and treatments. Tami Luhby of CNN, Shefali Luthra of The 19th, and Jessie Hellmann of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more.
-
Despite Doctors鈥 Concerns, Pharmacists Get More Leeway to Offer Treatment With Testing
In the battle against covid, pharmacies became a key place for consumers to seek vaccines and testing. Some states are expanding pharmacists鈥 work to include directly prescribing drugs for customers who seek some routine, point-of-care tests, such as those for flu or strep throat. But doctor groups oppose the move.
-
At a Tennessee Crossroads, Two Pharmacies, a Monkey, and Millions of Pills
Prosecutors say opioid-seeking patients drove hours to get their prescriptions filled in Celina, Tennessee, where pharmacies ignored signs of substance misuse and paid cash 鈥 or 鈥渕onkey bucks鈥 鈥 to keep customers coming back.
By Brett Kelman -
Big Pharma Is Betting on Bigger Political Ambitions From Sen. Tim Scott
The South Carolina senator led the congressional pack in pharma campaign contributions for the second half of 2021. There are clear reasons.
By Rachana Pradhan and Victoria Knight -
Campaign Contributions Tracker
Pharma Cash to Congress
A 51视频 Health News database tracks campaign donations from drugmakers over the past 10 years.
-
Pfizer CEO Pushes Yearly Shots for Covid. Not So Fast, Experts Say.
A corporate CEO鈥檚 call for a fourth mRNA shot struck those closely watching the pandemic as self-serving. It creates public pressure for a fourth dose of vaccine before government experts have time to assess the evidence and settle on the best course forward.
By Arthur Allen -
Covid鈥檚 鈥楽ilver Lining鈥: Research Breakthroughs for Chronic Disease, Cancer, and the Common Flu
Billions of dollars invested in mRNA vaccines and covid research could yield health care dividends for decades to come.
By Liz Szabo -
鈥楢n Arm and a Leg鈥: Need an Expensive Drug? Here’s What You Need to Know
Even a personal finance expert can get stuck with a huge unexpected bill for a drug. Listen up for what you need to know about "copay accumulators."